Background The effect of inhaled corticosteroids (ICS) on the clinical outcomes of patients
with coronavirus disease 2019 (COVID-19) was not known. Research design and methods …

Inhaled corticosteroids are known to be relatively safe for long-term use in inflammatory
respiratory diseases and it has been repurposed as one of the potential therapies for …

The influence of inhaled corticosteroids (ICS) on COVID-19 outcomes remains uncertain. To
address this, we conducted a systematic review and meta-analysis, analyzing 30 studies, to …

Background To assess the efficacy and safety of corticosteroids in COVID-19 patients
compared with standard care or placebo. Methods Electronic databases were searched to …

Background It is unclear the efficacy and safety of glucocorticoids compared with placebo or
usual care for treatment of COVID-19. Research design and methods Randomized …

Background COVID-19 is a type of pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection that was identified in December 2019 …

BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …

Objective Currently, corticosteroids are widely used to treat coronavirus disease 2019
(COVID-19) symptoms. However, the therapeutic role of corticosteroids remains highly …